| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director +2 more
43 companies
Ra Capital Management, L.P. is a Director, 10% Owner at WVE with holdings across 43 companies. Recent SEC Form 4 filings include 18 buys and 2 sells.
Estimated insider holdings value: $3402.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | TYRA Tyra Biosciences, Inc. | Director, 10% Owner | Buy | 1,211,198 | $9.70 | $11,751,303.68 | +6.6% | +21.1% | +161.9% | |
| May 14, 2025 | HOWL Werewolf Therapeutics, Inc. | Director, 10% Owner | Buy | 536,426 | $0.91 | $487,187.92 | +3.0% | +21.2% | -45.2% | |
| Mar 13, 2025 | MLYS Mineralys Therapeutics, Inc. | Director | Buy | 1,296,296 | $13.50 | $17,499,996.00 | +43.4% | +15.2% | +94.0% | |
| Mar 7, 2025 | JANX Janux Therapeutics, Inc. | Director, 10% Owner | Buy | 824,041 | $30.75 | $25,342,964.88 | +2.1% | -19.2% | -54.9% | |
| Feb 10, 2025 | SION Sionna Therapeutics, Inc. | Director, 10% Owner | Buy | 1,125,000 | $18.00 | $20,250,000.00 | +13.8% | -42.0% | +70.9% | |
| Nov 8, 2024 | TYRA Tyra Biosciences, Inc. | Director, 10% Owner | Buy | 1,220,681 | $16.25 | $19,836,066.25 | +16.3% | -18.2% | -11.1% | |
| Oct 28, 2024 | SEPN Septerna, Inc. | Director, 10% Owner | Buy | 4,170,000 | $18.00 | $75,060,000.00 | +147.6% | -22.1% | +7.6% | |
| Oct 18, 2024 | JANX Janux Therapeutics, Inc. | Director, 10% Owner | Buy | 1,200,000 | $44.75 | $53,700,000.00 | +14.8% | -18.8% | -46.5% | |
| Sep 16, 2024 | BCAX Bicara Therapeutics Inc. | Director, 10% Owner | Buy | 1,833,000 | $18.00 | $32,994,000.00 | +35.8% | -31.5% | -55.7% | |
| Aug 9, 2024 | ANTX An2 Therapeutics, Inc. | 10% Owner | Sell | 3,525,094 | $1.08 | $3,807,101.52 | -63.5% | +6.8% | +4.9% |